Results 151 to 160 of about 74,341 (223)

Clinical Validity of Imatinib Therapeutic Drug Monitoring in a Real-World Italian Cohort of Gastrointestinal Stromal Tumors and the Role of Patients' Sex. [PDF]

Pharmaceutics
Gagno S, Buonadonna A, Cecchin E, Fumagalli A, Posocco B, Canil G, Cecchin R, Guardascione M, Montico M, Puglisi F, Cecchin E.   +10 more
europepmc   +1 more source

Molecular and functional analysis of calcium binding by a cancer-linked calreticulin mutant. [PDF]

Elife
Tagoe INA, Kaur A, Quaye O, Tagoe EA, Koropatkin NM, Satin LS, Raghavan M.   +6 more
europepmc   +1 more source

Chronic Myeloid Leukemia Beyond BCR::ABL1 Inhibition: Resistance Mechanisms and Emerging Therapeutic Modalities. [PDF]

Pharmaceuticals (Basel)
Mihaylova R.
europepmc   +1 more source

Non-Coding RNAs in Gastrointestinal Stromal Tumors: Regulatory Networks, Drug Resistance, and Clinical Implications. [PDF]

Int J Mol Sci
Mandrakis G, Papadakos SP, Levidou G, Keratsa P, Christodoulou MI, Theocharis S.   +5 more
europepmc   +1 more source

Cell Death Induction by MO2455, a Novel Potential Anti-Cancer Agent in Monocytic and T-Cell Leukemia Cells. [PDF]

Cells
Vadi Velu A, Matsuno K, Saraswat B, Ohno O, Yingchun Y, Zhenkai Z, Tong Y, Tougan T, Aoshi T, Takamura T, Koizumi F, Masutani M.   +11 more
europepmc   +1 more source

Patient Care of Pregnant Women With Chronic Myeloid Leukemia in a Resource Limited Setting-Case Reports From Ghana. [PDF]

Case Rep Hematol
Benneh-Akwasi Kuma A, Hanson LL, Pepra-Ameyaw NB, Obeng GD, Csanádi M.   +4 more
europepmc   +1 more source

Meta-Analysis of Imatinib Resistance in Chronic Myeloid Leukemia due to BIM Gene Deletion and Single Nucleotide Polymorphisms Reveals Ethnic Variations in Prevalence. [PDF]

EJHaem
Bhattarai A, Kountouris D, Sah S, Mehta R, Sah R.   +4 more
europepmc   +1 more source

Extragastrointestinal stromal tumor involving the adrenal region: A rare case report. [PDF]

Rare Tumors
Cheng MH, Wang CA, Wang YH, Wang WJ.
europepmc   +1 more source

Long-Term Offspring Outcomes Following Parental Exposure to BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Retrospective Cohort Study with Follow-Up to 24.6 Years. [PDF]

Cancers (Basel)
Pál S, Solymár M, Alizadeh H.
europepmc   +1 more source